These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2133733)

  • 41. Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension.
    Olivari MT; Levine TB; Weir EK; Cohn JN
    Chest; 1984 Jul; 86(1):14-9. PubMed ID: 6734275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60].
    Iakovlev SV; Lazutin VK; Glezer MG; Chistova VS; Sergeeva EV
    Kardiologiia; 1987 Dec; 27(12):23-7. PubMed ID: 3444206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic effects of digoxin on congestive heart failure in old myocardial infarction, dilated cardiomyopathy, acute myocardial infarction and mitral stenosis.
    Kurogane K; Fujitani K; Fukuzaki H
    Jpn Heart J; 1985 Mar; 26(2):155-64. PubMed ID: 4009960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemodynamic studies of pulmonary heart diseases and the effects of nifedipine].
    Wu WQ; Rong ZS; Yang XQ
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):21-3. PubMed ID: 8045182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic performance during exercise in patients with severe chronic congestive heart failure before and after a single dose of pimobendan.
    Hagemeijer F
    J Cardiovasc Pharmacol; 1994 May; 23(5):741-6. PubMed ID: 7521456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of nifedipine and verapamil on isometric and dynamic exercise in normal subjects.
    Stein DT; Lowenthal DT; Porter RS; Falkner B; Bravo EL; Hare TW
    Am J Cardiol; 1984 Aug; 54(3):386-9. PubMed ID: 6465021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.
    Timmis AD; Smyth P; Kenny JF; Campbell S; Jewitt DE
    Br Heart J; 1984 Sep; 52(3):314-20. PubMed ID: 6466518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of calcium administration on the short-term hemodynamic and anti-ischemic effects of nifedipine.
    Wohns DH; Patterson JH; Clarke S; Dunlap S; Blauwet MB; Koch G; Adams KF
    J Am Coll Cardiol; 1991 Oct; 18(4):1070-6. PubMed ID: 1894852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure.
    Prida XE; Kubo SH; Laragh JH; Cody RJ
    Am J Med; 1983 Nov; 75(5):795-800. PubMed ID: 6638048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.
    Betocchi S; Cannon RO; Watson RM; Bonow RO; Ostrow HG; Epstein SE; Rosing DR
    Circulation; 1985 Nov; 72(5):1001-7. PubMed ID: 4042288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of intravenous nifedipine in the treatment of cardiac insufficiency in the acute period of myocardial infarction].
    Kosminskiĭ PG; Vasechkin SS; Vaniev SB; Magnitskiĭ AV; Gruzdev AK; Sidorenko BA
    Kardiologiia; 1991 Jan; 31(1):37-40. PubMed ID: 2046244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sublingual nifedipine controversy in drug delivery.
    Schumann D
    Dimens Crit Care Nurs; 1991; 10(6):314-20. PubMed ID: 1935527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
    Feldman AM; Becker LC; Llewellyn MP; Baughman KL
    Am Heart J; 1988 Sep; 116(3):771-7. PubMed ID: 3046278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Increase in liver circulation with nifedipine].
    Nitsch J; Kuhnen R; Lüderitz B
    Klin Wochenschr; 1986 Oct; 64(21):1113-8. PubMed ID: 3807257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement of exercise capacity after nifedipine in patients with Eisenmenger syndrome complicating ventricular septal defect.
    Wong CK; Yeung DW; Lau CP; Cheng CH; Leung WH
    Clin Cardiol; 1991 Dec; 14(12):957-61. PubMed ID: 1841020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of sublingual nifedipine on hemodynamic responses to exercise in patients with myocardial infarction].
    Fukui S; Tani A; Katoh O; Hamano Y; Minamino T
    Nihon Naika Gakkai Zasshi; 1985 May; 74(5):558-63. PubMed ID: 4031584
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of the optimal dose of finoptin on various components of the circulatory system in heart failure in patients with ischemic heart disease].
    Denisiuk VI; Belokonnaia NS
    Kardiologiia; 1990 Jul; 30(7):72-4. PubMed ID: 2232469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy.
    Nishizaki M; Ogawa A; Matsubara H
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33532477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of nicardipine and nifedipine in chronic heart failure: a non invasive study.
    Mazzola C; Vaccarella A; Guffanti E; Colnago R; Scarpazza P; Turri DR; Fiorella G
    Cardiologia; 1987 Jul; 32(7):637-42. PubMed ID: 3690587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.